Display options
Share it on

EFSA J. 2018 Jul 12;16(7):e05337. doi: 10.2903/j.efsa.2018.5337. eCollection 2018 Jul.

Safety and efficacy of vitamin B.

EFSA journal. European Food Safety Authority

Guido Rychen, Gabriele Aquilina, Giovanna Azimonti, Vasileios Bampidis, Maria de Lourdes Bastos, Georges Bories, Andrew Chesson, Pier Sandro Cocconcelli, Gerhard Flachowsky, Jürgen Gropp, Boris Kolar, Maryline Kouba, Marta López-Alonso, Secundino López Puente, Alberto Mantovani, Baltasar Mayo, Fernando Ramos, Maria Saarela, Roberto Edoardo Villa, Pieter Wester, Lucio Costa, Noël Dierick, Boet Glandorf, Lieve Herman, Sirpa Kärenlampi, Lubomir Leng, Christoph Tebbe, Jaime Aguilera, Paola Manini, Jordi Tarrés-Call, Robert John Wallace

PMID: 32625973 PMCID: PMC7009745 DOI: 10.2903/j.efsa.2018.5337

Abstract

The European Commission asked EFSA for an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of a riboflavin-based additive (minimum 80%) produced by a genetically modified strain of

© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Keywords: Ashbya gossypii; efficacy; genetically modified microorganism; nutritional additive; riboflavin; safety; vitamin B2

References

  1. Appl Microbiol Biotechnol. 2000 May;53(5):509-16 - PubMed
  2. Science. 2004 Apr 9;304(5668):304-7 - PubMed
  3. Food Funct. 2012 May;3(5):487-502 - PubMed

Publication Types